These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 33422195

  • 1. The Pursuit of Risk Assessment and Stratification Tools in Pulmonary Arterial Hypertension: Have We Seen the Lite?
    Ford HJ, LeVarge B.
    Chest; 2021 Jan; 159(1):14-16. PubMed ID: 33422195
    [No Abstract] [Full Text] [Related]

  • 2. The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.
    Haarman MG, Douwes JM, Ploegstra MJ, Roofthooft MTR, Vissia-Kazemier TR, Hillege HL, Berger RMF.
    Am J Respir Crit Care Med; 2019 Nov 15; 200(10):1312-1315. PubMed ID: 31298925
    [No Abstract] [Full Text] [Related]

  • 3. Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
    Humbert M, Lau EMT.
    Am J Respir Crit Care Med; 2021 Mar 15; 203(6):675-677. PubMed ID: 33357026
    [No Abstract] [Full Text] [Related]

  • 4. [Risk stratification methods and their significance in pulmonary arterial hypertension].
    Avdeev SN, Tsareva NA.
    Ter Arkh; 2019 Sep 15; 91(9):150-157. PubMed ID: 32598827
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.
    Pausch C, Pittrow D, Hoeper MM, Huscher D.
    Eur Respir J; 2023 Nov 15; 62(5):. PubMed ID: 37802633
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gaps of evidence in pulmonary arterial hypertension.
    Vizza CD, Ghio S, Badagliacca R, Manzi G, Scelsi L, Argiento P, D'Alto M.
    Int J Cardiol; 2022 Oct 01; 364():119-123. PubMed ID: 35716936
    [No Abstract] [Full Text] [Related]

  • 10. [Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension].
    Shariya AM, Martynyuk TV, Shariya MA, Ustyuzhanin DV.
    Ter Arkh; 2023 May 31; 95(4):291-295. PubMed ID: 38158975
    [Abstract] [Full Text] [Related]

  • 11. Prognostic Stratification and Treatment for Pulmonary Arterial Hypertension. Gaps and Promising Remedies.
    Del Pozo R, Cruz-Utrilla A, Escribano-Subias P.
    Arch Bronconeumol; 2023 Oct 31; 59(10):617-618. PubMed ID: 37147267
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI: The Need for Collaboration and Standardization.
    Frantz RP, Swift AJ.
    Chest; 2024 Jan 31; 165(1):12-13. PubMed ID: 38199727
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
    Aman J, Hovingh GK.
    Thorax; 2019 Apr 31; 74(4):317-318. PubMed ID: 30679265
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
    Austin ED, Hamid R.
    Am J Respir Crit Care Med; 2020 Jun 01; 201(11):1329-1331. PubMed ID: 32053755
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.